Overcoming Antibiotic Resistance and Treating Bacterial Infections with Biological Nanoparticles

Area of Science:

• Nanomedicine
• Biotechnology
• Microbiology

Background:

• Antibiotics have been primary treatments for bacterial infections for over 80 years.
• The increasing prevalence of antibiotic-resistant pathogens necessitates alternative therapeutic strategies.
• Nanotechnology, particularly bio-derived nanoparticles, presents a promising avenue for novel antimicrobial treatments.

Purpose of the Study:

• To review recent advancements in the design, characterization, and application of biological nanoparticles for combating bacterial infections.
• To highlight the mechanisms of action and therapeutic potential of these nanoparticles.
• To identify key research directions for accelerating the clinical translation of biological nanoparticle-based therapies.

Main Methods:

• Review of current literature on bio-derived nanoparticles, including extracellular vesicles (exosomes, outer membrane vesicles) and cell membrane-coated nanoparticles (CMNPs).
• Analysis of the physicochemical and biological properties of these nanoparticles relevant to antimicrobial therapy.
• Synthesis of information on their mechanisms of action, therapeutic efficacy, and challenges in clinical application.

Main Results:

• Biological nanoparticles, such as exosomes, bacterial outer membrane vesicles (OMVs), and engineered cell membrane-coated nanoparticles (CMNPs), exhibit unique properties beneficial for antimicrobial applications.
• These nanoparticles demonstrate intrinsic bioactivity, biocompatibility, and structural versatility, enabling diverse therapeutic strategies.
• Current research focuses on harnessing these properties to overcome antibiotic resistance and develop effective treatments.

Conclusions:

• Biological nanoparticles represent a significant advancement in the search for alternatives to conventional antibiotics.
• Further research into their mechanisms, optimization, and clinical translation is crucial for realizing their full potential in combating bacterial infections.
• These nanomaterials offer a versatile platform for developing next-generation antimicrobial therapies to address the global challenge of antibiotic resistance.